RxSight (RXST) Current Assets (2020 - 2026)
RxSight's (RXST) quarterly Current Assets came in at $279.2 million in Q1 2026, down 3.19% YoY from $288.4 million in Q1 2025, and down 2.86% on a QoQ basis from $287.5 million in Q4 2025.
RxSight (RXST) Current Assets (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Current Assets data on file, last reported at $279.2 million in Q1 2026.
- Quarterly Current Assets fell 3.19% year-over-year to $279.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $279.2 million (down 3.19% YoY) and the FY2025 annual result came in at $287.5 million, down 2.17% from the prior year.
- Current Assets slipped to $279.2 million in Q1 2026, from $287.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $293.8 million in Q4 2024 to a low of $134.6 million in Q4 2022.
- A 5-year average of $220.1 million and a median of $187.7 million in 2023 frame the typical range for Current Assets.
- The widest YoY moves for Current Assets: up 98.46% in 2022, down 25.32% in 2022.
- Tracing RXST's Current Assets over 5 years: stood at $134.6 million in 2022, then climbed by 25.16% to $168.4 million in 2023, then jumped by 74.47% to $293.8 million in 2024, then decreased by 2.17% to $287.5 million in 2025, then fell by 2.86% to $279.2 million in 2026.
- The last three Current Assets figures came in at $279.2 million (Q1 2026), $287.5 million (Q4 2025), and $283.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 2.45 Bn |
| 10 | RxSight | 254.75 Mn | -149.49 Mn | - | 327.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 327.40 Mn |
| Mar 31, 2026 | 279.23 Mn |
| Dec 31, 2025 | 287.46 Mn |
| Sep 30, 2025 | 283.88 Mn |
| Jun 30, 2025 | 283.87 Mn |
| Mar 31, 2025 | 288.41 Mn |
| Dec 31, 2024 | 293.82 Mn |
| Sep 30, 2024 | 286.77 Mn |
| Jun 30, 2024 | 281.22 Mn |
| Mar 31, 2024 | 168.56 Mn |
| Dec 31, 2023 | 168.41 Mn |
| Sep 30, 2023 | 167.95 Mn |
| Jun 30, 2023 | 180.45 Mn |
| Mar 31, 2023 | 187.67 Mn |
| Dec 31, 2022 | 134.56 Mn |
| Sep 30, 2022 | 139.16 Mn |
| Jun 30, 2022 | 149.93 Mn |
| Mar 31, 2022 | 161.15 Mn |
| Dec 31, 2021 | 176.30 Mn |
| Sep 30, 2021 | 186.34 Mn |